Exercise may shield hearts from chemo damage, new study hopes

NCT ID NCT04467411

Ongoing Knowledge-focused Sponsor: University of Aberdeen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a physical exercise program can prevent heart damage in breast cancer patients receiving a type of chemotherapy called anthracycline. About 70 participants will be randomly assigned to exercise or usual care. Researchers will use heart scans and blood tests to see if exercise helps keep the heart healthy and to detect early warning signs of trouble.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: physical exercise intervention
What this could lead to: If successful, this could point toward a simple, drug-free way to protect the heart during breast cancer chemotherapy.
What could go wrong: This is a small, early-stage study (70 participants) focused on detecting early heart changes, not yet proving that exercise prevents heart failure. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Cardiac Research Office, Aberdeen Royal Infirmary

Aberdeen, Aberdeenshire, AB25 2ZD, United Kingdom
Cardiovascular Research Facility

Aberdeen, Aberdeenshire, AB25 2ZD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.